Angeliki Magklara is an Αssociate Professor of Clinical Chemistry at the Department of Medicine, School of Health Sciences, University of Ioannina. She received her Bachelor's degree from the Department of Biology and her Master's degree in Clinical Biochemistry from the Department of Chemistry at the National and Kapodistrian University of Athens. She completed her PhD degree at the Department of Laboratory Medicine and Pathobiology at the University of Toronto in Canada, where she worked on the characterization of new members of the human kallikrein gene family and their evaluation as potential new tumor biomarkers. Dr. Magklara did her post-doctoral training at the Laboratory of Receptor Biology and Gene Expression at the National Institutes of Health (NCI/NIH) in Bethesda, Maryland, USA, where she worked on mechanisms of action of the progesterone receptor in breast cancer. Later on, she moved to the University of California in San Francisco (UCSF), where she worked on the mechanisms of epigenetic regulation of the olfactory receptor genes. In 2012 she was awarded a Marie Curie Career Integration Grant and she moved back to Greece, where she joined the Biomedical Research Institute of FORTH at Ioannina. In 2014, she assumed her academic position at the University of Ioannina. Her current research interests lie in the field of cancer epigenetics, cancer stem cells and liquid biopsies.